🇺🇸 FDA
Patent

US 12084497

SIRP1α targeted chimeric proteins and uses thereof

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 12084497 (SIRP1α targeted chimeric proteins and uses thereof) held by Orionis Biosciences, Inc expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P35/00